|
Full Symposia:
Of Vice and Men: Shared Brain Vulnerabilities for Drug and Non-Drug (Food, Sex, Gambling) Rewards
Anna Rose Childress, Ph.D., Chair and Mark Potenza, M.D., Ph.D., Co-chair
Traffick Signals and Addictive Processes
Kathryn Cunningham, Ph.D., Chair and Toni Shippenberg, Ph.D., Co-chair
Cocaine Dependence and Social Disadvantage: Evidence from the Laboratory, Clinic, and Community
Stephen Higgins, Ph.D., Chair
Advances in the Development of Medications for Comorbid ADHD and Substance Use Disorders
Petra Jacobs, Ph.D., Chair and Frances Levin, M.D., Co-chair
Adults May Be from Mars but Adolescents Are from Venus
Minda Lynch, Ph.D., Chair and James Bjork, Ph.D., Co-Chair
Pharmacogenetics of the Safety and Efficacy of Medications for the Treatment of Addictions
Ivan Montoya, M.D., M.P.H., Chair and Joni Rutter, Ph.D., Co-chair
Addiction Liability and Pain Relief Medication: Raymond Houde Memorial Symposium
Charles O’Brien, M.D., Ph.D., Chair and Charles Inturrisi, Ph.D., Co-chair
Understanding Extinction Learning and Its Translation to Drug Addiction
Paul Schnur, Ph.D., Chair and David Shurtleff, Ph.D., Co-chair
The Consequences of Chronic Cannabis Abuse: From Neurochemistry to Treatment
Philip Terry, Ph.D., Chair
Opioid Analgesics: Protecting their Use and Preventing Abuse
Sharon Walsh, Ph.D., Chair and Sidney Schnoll, M.D., Ph.D., Co-chair
Preclinical Research on the Discovery of Glutamatergic Therapeutics for the Treatment of Addictions
David White, Ph.D., Chair and Athina Markou, Ph.D., Co-chair
Mini Symposia:
The Twin Design: Studying Genes and Environment on Substance Use Behaviors
Arpana Agrawal, Ph.D., Chair and Michael Lynskey, Co-Chair
Sexual Acquisition and Transmission of HIV from and among Drug-Using Populations
Martin Iguchi, Ph.D., Chair and Richard Jenkins, Ph.D., Co-chair
Neonatal Responses to Maternal Substance Use
Karol Kaltenbach, Ph.D., Chair and Loretta Finnegan, M.D., Co-Chair
Innovative Applications of Technology to the Prevention and Treatment of Substance Use Disorders
Lisa Marsch, Ph.D., Chair and Kathleen Carroll, Ph.D., Co-Chair
Functional and Clinical Relevance of Opioid Receptor Heterodimers
Philip Portoghese, Ph.D., Chair and Ajay Yekkirala, Co-Chair
Workshops:
A Step-By-Step Guide to Analysis of Epidemiological Field Survey Data
Jim Anthony, Ph.D., Chair and Silvia Martins, MD, Ph.D., Co-Chair
What’s New at NIDA and NIH: A Peek into the Black Box
Mark R. Green, Ph.D., Chair and Teri Levitin, Ph.D., Co-Chair
NIDA International Research Poster Session
Steven Gust, Ph.D., Chair
Challenges for Abuse Liability Testing from Drug Development to FDA Approval
Mike Nader, Ph.D., Chair and Beatriz Rocha, Ph.D., Co-Chair
14th Annual Contingency Management Working Group
Stacy Sigmon, Ph.D., Chair and Kelly Dunn, M.A., Co-Chair
Organizing a Special Interest Group on Stress and Addiction
Rajita Sinha, Ph.D., Chair and Helen Wu, Ph.D., Co-Chair
DEA’s Drug and Chemical Evaluation Section: The Scientists Behind the Badge. The Role of the Scientific Staff within DEA and Resources for CPDD
Christine Sannerud, Ph.D., Chair and Srihari Tella, Ph.D., Co-Chair
Innovative Technology Transfer and Information Dissemination Strategies: Results from Five ATTC-Sponsored Initiatives
Anne Helene Skinstad, Ph.D., Chair and Paula Horvatich, Ph.D., Co-Chair
Adolescent Substance Abuse Treatment: Current Findings and Implications for Juvenile Justice Settings
Lyn Stein, Ph.D., Chair and Michael Dennis, Ph.D., Co-Chair
Academic Success & Tenure in Tight Times
Mark Swieter, Ph.D., Chair and Teri Levitin, Ph.D., Co-Chair
From an Acute Care Model to a Recovery Managed Care Model: What Do We Know and Where Do We Go from Here?
Ken Winters, Ph.D., Chair and Anne Helene Skinstad, Ph.D., Co-Chair
|
Search 
